Mark Johnson

Mark Johnson is an Associate Scientist at Gameto, a biotechnology company focused on developing therapeutics for diseases of the female reproductive system. In this role since April 2023, Mark contributes to the program Fertilo, which aims to enhance the IVF and egg-freezing processes. Prior to joining Gameto, Mark worked as a Research Associate at Applied Biological Laboratories Inc. from September 2021 to April 2023 and served as a Research Technician at Weill Cornell Medicine from October 2020 to September 2021. Mark earned a degree from the University of Massachusetts Amherst between 2016 and 2020.